Conclusions
Loss of weight, exercise and abstinence from smoking constitute the first line of therapy for patients with intermittent claudication, together with control of high blood pressure. An attempt to correct lipid abnormalities seems worthwhile, especially in younger patients. Reconstructive vascular surgery or percutaneous transluminal dilatation are effective in a large proportion of patients, but lumbar sympathectomy is of little value in most patients. Stating the role of more specific drug treatment is more problematic. Agents which reduce blood viscosity, platelet inhibitors and vasodilators have been tried but the evidence supporting their efficacy remains unconvincing. Long term use of anticoagulants has not resulted in a convincing advantage in terms of morbidity or mortality.
Similar content being viewed by others
References and Further Reading
Alinaji, M.D.; Baker, CF.; Berkowitz, H.D.; Chu, J. and Roberts, B.: Femoropopliteal vein grafts for claudication. Analysis of 100 consecutive cases. Annals of Surgery 188: 79–82 (1978).
Barndt, R.; Blankenhorn, D.H.; Crawford, D.W. and Brooks, S.H.: Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients. Annals of Internal Medicine 86: 139–146 (1977).
Barnes, R.W.; Baker, W.H.; Shanik, G.; Maixner, W.; Hayes, A.C.; Lin, R. and Clarke, W.: Value of concomitant sympathectomy in aortoiliac reconstruction. Results of a prospective, randomized study. Archives of Surgery 112: 1325–1330 (1977).
Brewster, D.C. and Darling, R.C.: Optimal methods of aortoiliac reconstruction. Surgery 84: 739–747 (1978).
Burkhalter, A.; Widmer, L.K. and Glaus, L.: Chronischer Gliedmassenarterienverschluss und Langzeitantikoagulation. VASA (Journal for Vascular Diseases) 3: 185–189 (1974).
Bylund, A.C.; Hammersten, J.; Holm, J. and Scherstén, T.: Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency. European Journal of Clinical Investigation 6: 425–429(1976).
Clyne, C.A.C.: Non-surgical management of peripheral vascular disease: A review. British Medical Journal 281: 794–795 (1980).
Coffman, J.D.: Effect of vasodilator drugs in vasoconstricted normal subjects. Journal of Clinical Pharmacology 8: 302–308 (1968).
Coffman, J.D.: Vasodilator drugs in peripheral vascular disease. American Journal of Hospital Pharmacy 32: 1276–1281 (1976).
Coffman, J.D.: Vasodilator drugs in peripheral vascular disease. New England Journal of Medicine 300: 713–717 (1979).
Committee of Principal Investigators: A cooperative trial in the prevention of ischaemic heart disease using clofibrate. British Heart Journal 40: 1069–1118 (1978).
Committee of Principal Investigators: WHO cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: Mortality follow-up. Lancet 2: 379–386(1980).
Cotton, L.T. and Roberts, V.C.: Extended deep femoral angioplasty: An alternative to femoropopliteal bypass. British Journal of Surgery 62: 340–343 (1975).
Dahllöf, A.; Björntrop, P.; Holm, J. and Schwerstén, T.: Metabolic activity in skeletal muscle in patients with peripheral arterial insufficiency: Effect of physical training. European Journal of Clinical Investigation 4: 9–15 (1974).
DeWeese, J.A. and Rob, C.G.: Autogenous venous bypass grafts ten years later. Annals of Surgery 82: 775–784 (1977).
Dormandy, J.A.; Hoare, E.; Colley, J.; Arrowsmith, D.E. and Dormandy, T.L.: Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. British Medical Journal 2: 576–581 (1973).
Dormandy, J.A.; Gutteridge, J.M.C.; Hoare, E. and Dormandy, T.L.: Effect of clofibrate on blood viscosity in intermittent claudication. British Medical Journal 1: 259–262 (1974).
Dormandy, J.A.; Goyle, K.B. and Reid, H.L.: Treatment of severe intermittent claudication by controlled defibrination. Lancet 1: 625–626(1977).
Ehringer, H.; Dudczak, R.; Lechner, K. and Widhalm, F.: Therapeutische Defibrinierung mit Schlangengift bei arteriellen Durchblutungsstörungen. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 624–627 (1972).
Ehrly, A.M.: Improvement of the flow properties of blood: A new therapeutic approach in occlusive arterial disease. Angiology 27: 188–195 (1976).
Ekroth, R.; Dahlhöf, A.G.; Gundevall, B.; Holm, J. and Scherstén, T.: Physical training of patients with intermittent claudication: Indications, methods, and results. Surgery 84: 640–643 (1978).
Enger, S.C.; Herbjornsen, K.; Erikssen, J. and Fretland, A.: HDL and physical activity: The influence of physical exercise, age and smoking on HDL-cholesterol and the HDL-total cholesterol ratio. Scandinavian Journal of Laboratory Investigation 37: 251–255(1977).
Freiman, D.B.; Ring, E.J.; Oleaga, J.A.; Berkowitz, H. and Roberts, B.: Transluminal angioplasty of the iliac, femoral, and popliteal arteries. Radiology 132: 285–288 (1979).
Gillespie, J.A.: An evaluation of vasodilator drugs in occlusive vascular disease by measurement. Angiology 17: 280–288 (1966).
Grüntzig, A. and Hopff, H.: Rekanalisation chronischer arterieller Verschlüsse mit einem neuen Dilatationskatheter. Deutsche Medizinische Wochenschrift 99: 2502–2510 (1974).
Grüntzig, A. and Kumpe, D.A.: Technique of percutaneous transluminal angioplasty with the Grüntzig balloon catheter. American Journal of Roentgenology, Radium Therapy and Nuclear Medicine 132: 547–552 (1979).
Hangsteen, V. and Lorensen, E.: Vasodilator drugs in the treatment of peripheral arterial insufficiency. Thesis, Oslo University Medical School, Oslo, p.62 (1974).
Hughes-Davies, D.I. and Redman, R.: Chemical lumbar sympathectomy. Anaesthesia 31: 1068–1075 (1976).
Hughson, W.G.; Mann, J.E. and Garrod, A.: Intermittent claudication: Prevalence and risk factors. British Medical Journal 1: 1379–1381 (1978).
Imperato, A.M.: Lumbar sympathectomy: Role in the treatment of occlusive arterial disease of the lower extremities. Surgical Clinics of North America 59: 719–735 (1979).
Jonason, T.; Jonzon, B.; Ringqvist, I. and Oman-Rydbug, A.: Effect of physical training in different categories of patients with intermittent claudication. Acta Medica Scandinavica 206: 253–258(1979).
Juergens, J.L.; Barker, N.W. and Hines, E.A.,Jr: Arteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 21: 188–195 (1960).
Katzen, B.T. and Chang, J.: Percutaneous transluminal angioplasty with the Grüntzig balloon catheter. Radiology 130: 623–626 (1979).
Kremer, V.G.J.; Niemezyk, H.; Poeplau, W. and Nicolesen, R.F.: Hyperlipoproteinämien bei peripheren arteriellen Verschluss-krankheiten. Münchener Medizinische Wochenschrift 115: 662–666(1973).
Larsen, A. and Lassen, N.: Effect of daily muscular exercise in patients with intermittent claudication. Lancet 2: 1093–1096 (1966).
Lowe, G.D.O.; Dunlop., D.J.; Lawson, D.H.; Pollock, J.G.; Watt, J.K.; Forbes, CD.; Prentice, C.R.M. and Drummond, M.M.: Double-blind controlled clinical trial of Ancrod for ischaemic rest pain of the leg. Angiology 33(No. 1): 46–50 (1982).
Malone, J.M.; Moore, W.S. and Goldstone, J.: The natural history of bilateral aortofemoral bypass grafts for ischemia of the lower extremities. Archives of Surgery 110: 1300–1306 (1975).
Martin, M.: Thrombolytic therapy in arterial thromboembolism. Progress in Cardiovascular Diseases 21: 351–374 (1979).
Martin, P. and Jamieson, C.: The rationale for and measurement after profundaplasty. Surgical Clinics of North America 54: 95–109(1974).
Martin, M.; Engelken, HJ.; Tambert, F.; Martin, U.; Hirdes, E. and Auel, H.: Die Defibrinierungstherapie mit einem Thrombin-ähnlichen Schlangengiftenenzym (Defibrase). Gerinnungsphysiologische Beobachtungen und klinische Erfahrungen. VASA (Journal for Vascular Diseases) [Suppl. 5]: 1–39 (1976).
Mashiah, A.; Patel, P.; Schraibman, I.G. and Charlesworth, D.: Drug therapy in intermittent claudication: An objective assessment of the effects of three drugs in patients with intermittent claudication. British Journal of Surgery 65: 342–345 (1978).
Myers, K.A.; King, R.B. and Scott N.: The effect of smoking on the late patency of arterial reconstruction on the legs. British Journal of Surgery 65: 267–271 (1978).
Nevelsteen, A.; Suy, R.; Daenen, W.; Boel, A. and Stalpaert, G.: Aortofemoral grafting. Factors influencing late results. Surgery 88: 642–653 (1981).
Offerhaus, L.: Indicaties en uitwerking van vaatverwijdende middelen, in het bijzonder bij cerebrale en perifere vaatsclerose. Nederlands Tijdschrift voor Geneeskunde 125: 228–234 (1981).
Oliver, M.F.: Serum cholesterol — The knave of hearts and the joker. Lancet 2: 1090–1095 (1981).
Postlethwaite, J.A. and Dormandy, J.A.: Results of ankle systolic pressure measurements in patients with intermittent claudication being treated with clofibrate. Annals of Surgery 181: 799–802(1975).
Schetz, J.; Bostoen, H.; Clement, D.; Fornhoff, M.; Haerens, A.; Roekaerts, P. and Staessen, A.J.: Flunarizine in chronic obstructive peripheral arterial disease: A placebo-controiled, double-blind, randomized multicentre trial. Current Therapeutic Research 23: 121–130 (1978).
Schoop, W.: Mechanism of beneficial action of daily walking training of patients with intermittent claudication. Scandinavian Journal of Clinical and Laboratory Investigation 31(Suppl. 128): 197–199(1973).
Skinner, J.S. and Strandness, D.E.: Exercise and intermittent claudication. II. Effect of physical training. Circulation 36: 23–29(1967).
Van Vroonhove, J.M.V. and Slot, H.B.: A critical review of the literature on long-term treatment of peripheral arteriosclerosis with oral anticoagulants. Archivum Chirurgicum Neerlandicum 28: 243–249 (1976).
Verhaeghe, R.; Van Hoof, A. and Beyens, G.: Controlled trial of Suloctidil in intermittent claudication. Journal of Cardiovascular Pharmacology 3: 279–286 (1981).
Verstraete, M.: Traitement par les anticoagulants au long cours dans les artériopathies chroniques des membres inférieurs. Semaine des Hôpitaux Paris Thérapeutique 52: 221–226 (1976).
Verstraete, M.: Drugs acting on the peripheral circulation. Drugs affecting blood viscosity; in Dukes (Ed.) Side Effects of Drugs, No. 4, pp. 139–143 (Excerpta Medica, Amsterdam 1980a).
Verstraete, M.: Guidelines for clinical trials set up to determine the usefulness of drugs in patients with symptoms ascribed to decreased flow in a particular vascular area; in Verstraete (Ed.) Methods in Angiology, pp.400–403 (Martinus Nijhoff Publishers, The Hague, Boston, London 1980b).
Verstraete, M.: Les antiagrégants plaquettaires. Revue du Praticien 31: 509–517(1981).
Verstraete, M.; Vermylen, J. and Verhaeghe, R.H.: Peripheral arterial diseases; in Prentice (Ed.) Thrombosis — Clinics in Haematology, No. 10 pp.669–689 (W.B. Saunders, London, Philadelphia, Toronto 1981).
Waibel, P.P. and Wolff, G.: The collateral circulation in occlusion of the femoral artery: an experimental study. Surgery 60: 912–918(1966).
Yates, C.J.P.; Bernt, A.; Andrews, V. and Dormandy, J.A.: Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet 2: 166–168 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verstraete, M. Current Therapy for Intermittent Claudication. Drugs 24, 240–247 (1982). https://doi.org/10.2165/00003495-198224030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198224030-00004